Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 215 publications
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".
Journal: Annals of neurology
Published: March 17, 2026
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 13, 2026
Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".
Journal: Annals of neurology
Published: November 24, 2025
Reply to "New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond".
Journal: Annals of neurology
Published: November 07, 2025
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.
Journal: Lancet (London, England)
Published: October 30, 2025
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 29, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 21, 2025
An optimized MP2RAGE protocol for spinal cord imaging in multiple sclerosis.
Journal: AJNR. American journal of neuroradiology
Published: October 13, 2025
Last Updated: 09/26/2026